Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03555877
Title Anti-hormonal Therapie With Ribociclib in HR-positive / HER2- Negative Metastatic Breast Cancer (AMICA)
Recruitment Recruiting
Gender female
Phase Phase II
Variant Requirements No
Sponsors German Breast Group
Indications

Her2-receptor negative breast cancer

Therapies

Anastrozole

Fulvestrant

Fulvestrant + Ribociclib

Letrozole

Exemestane + Ribociclib

Letrozole + Ribociclib

Anastrozole + Ribociclib

Exemestane

Age Groups: adult | senior
Covered Countries


No variant requirements are available.